← Leaderboards
Lirong Wang
University Of Pittsburgh At Pittsburgh
$2,074,929
Attributed
$6,036,065
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,036,065 · 2
By mechanism
R01$5,658,622 · 1
R56$377,443 · 1
Top collaborators
- Julia K Kofler9 shared
- Robert A Sweet9 shared
- Xiang-Qun Xie1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Gregory F Cooper$10,856,842
- Ivet Bahar$22,253,131
- Julia K Kofler$9,913,650
- Robert A Sweet$35,026,835
- Xia Jiang$1,722,603
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposImpaired CognitionS DiseasePharmaceutical PreparationsDisease ProgressionProteinsProteomeHallucinationsProteomicsPostsynapticActinsMortalityPostsynaptic Density ProteinMouse ModelDisabilityDelusionsLinkCaregiver BurdenBehaviorAmyloid Beta-ProteinDensityExcess MortalityPhenotypePrevent
Grant awards (10)
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$945,233
R01 · FY2025 · MH
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$787,106
R01 · FY2024 · MH
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P - Supplement$158,127
R01 · FY2024 · MH
Accelerating Treatment Development for Psychosis in AD: MODEL-AD+P$787,106
R01 · FY2023 · MH
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2022 · MH
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2021 · MH
Synaptic Resilience to Psychosis in Alzheimer Disease$589,988
R01 · FY2020 · MH
Synaptic Resilience to Psychosis in Alzheimer Disease$745,305
R01 · FY2019 · MH
Personalized Combination Therapy for AD with Common Comorbidities$377,443
R56 · FY2019 · AG
Synaptic Resilience to Psychosis in Alzheimer Disease$465,781
R01 · FY2018 · MH